198 related articles for article (PubMed ID: 38268162)
1. [Microbiome and Biliary Tract Cancer].
Park JS
Korean J Gastroenterol; 2024 Jan; 83(1):1-5. PubMed ID: 38268162
[TBL] [Abstract][Full Text] [Related]
2. Biliary tract microbiota: a new kid on the block of liver diseases?
Nicoletti A; Ponziani FR; Nardella E; Ianiro G; Gasbarrini A; Zileri Dal Verme L
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2750-2775. PubMed ID: 32196626
[TBL] [Abstract][Full Text] [Related]
3. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
Wheatley RC; Kilgour E; Jacobs T; Lamarca A; Hubner RA; Valle JW; McNamara MG
Br J Cancer; 2022 Mar; 126(5):693-705. PubMed ID: 34663949
[TBL] [Abstract][Full Text] [Related]
4. Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy.
Ye C; Dong C; Lin Y; Shi H; Zhou W
Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894256
[TBL] [Abstract][Full Text] [Related]
5. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy.
Khan FH; Bhat BA; Sheikh BA; Tariq L; Padmanabhan R; Verma JP; Shukla AC; Dowlati A; Abbas A
Semin Cancer Biol; 2022 Nov; 86(Pt 3):732-742. PubMed ID: 34273520
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma-A Scoping Review.
Lederer AK; Rasel H; Kohnert E; Kreutz C; Huber R; Badr MT; Dellweg PKE; Bartsch F; Lang H
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764207
[TBL] [Abstract][Full Text] [Related]
7. 16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer.
Lee H; Lee HK; Min SK; Lee WH
World J Surg Oncol; 2020 Jan; 18(1):19. PubMed ID: 31980025
[TBL] [Abstract][Full Text] [Related]
8. Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.
Saab M; Mestivier D; Sohrabi M; Rodriguez C; Khonsari MR; Faraji A; Sobhani I
PLoS One; 2021; 16(3):e0247798. PubMed ID: 33690612
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
10. Association of Microbial Dysbiosis with Gallbladder Diseases Identified by Bile Microbiome Profiling.
Choi SJ; Kim Y; Jeon J; Gwak HJ; Kim M; Kang K; Kim Y; Jeong J; Jung YK; Lee KG; Choi HS; Jung DH; Lee SG; Lee Y; Shin SJ; Jang K; Rho M; Choi D
J Korean Med Sci; 2021 Jul; 36(28):e189. PubMed ID: 34282606
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors.
Miyazaki M; Takada T; Miyakawa S; Tsukada K; Nagino M; Kondo S; Furuse J; Saito H; Tsuyuguchi T; Chijiiwa K; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):15-24. PubMed ID: 18274840
[TBL] [Abstract][Full Text] [Related]
12. Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.
Li YC; Li KS; Liu ZL; Tang YC; Hu XQ; Li XY; Shi AD; Zhao LM; Shu LZ; Lian S; Yan ZD; Huang SH; Sheng GL; Song Y; Liu YJ; Huan F; Zhang MH; Zhang ZL
Front Immunol; 2022; 13():1049812. PubMed ID: 36389727
[TBL] [Abstract][Full Text] [Related]
13. Unveiling microbiome profiles in human inner body fluids and tumor tissues with pancreatic or biliary tract cancer.
Okuda S; Hirose Y; Takihara H; Okuda A; Ling Y; Tajima Y; Shimada Y; Ichikawa H; Takizawa K; Sakata J; Wakai T
Sci Rep; 2022 May; 12(1):8766. PubMed ID: 35610303
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
15. The association between biliary tract cancers and cancers of other sites.
Su Y; Ahsan H; Neugut AI
Am J Gastroenterol; 1999 Aug; 94(8):2256-62. PubMed ID: 10445559
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic trends and geographic distribution of patients with gallbladder and extrahepatic biliary tract cancers in Canada.
Xiao Y; Cattelan L; Lagacé F; Ghazawi FM; Alakel A; Grose E; Le M; Nechaev V; Sasseville D; Waschke K; Litvinov IV
HPB (Oxford); 2021 Oct; 23(10):1541-1549. PubMed ID: 33863655
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiome: A Potential Modifiable Risk Factor in Biliary Atresia.
Jain V; Alexander EC; Burford C; Verma A; Dhawan A
J Pediatr Gastroenterol Nutr; 2021 Feb; 72(2):184-193. PubMed ID: 33427793
[TBL] [Abstract][Full Text] [Related]
18. Imaging of malignancies of the biliary tract- an update.
Hennedige TP; Neo WT; Venkatesh SK
Cancer Imaging; 2014 Apr; 14(1):14. PubMed ID: 25608662
[TBL] [Abstract][Full Text] [Related]
19. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases.
Binda C; Gibiino G; Coluccio C; Sbrancia M; Dajti E; Sinagra E; Capurso G; Sambri V; Cucchetti A; Ercolani G; Fabbri C
Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208765
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety.
Li KJ; Chen ZL; Huang Y; Zhang R; Luan XQ; Lei TT; Chen L
Respir Res; 2019 Dec; 20(1):272. PubMed ID: 31796027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
